Informed consent for testing or disclosure
HRS §325-16
in effect325-16. Informed consent for testing or disclosure
(a) A health care provider may subject a person's body fluids or tissue to a test for the presence of human immunodeficiency virus infection after:
(1) Orally explaining to the person that certain
personalized test results are maintained by the department of health, according
to strict confidentiality protocols established by law;
(2) Orally advising the person that free and
anonymous human immunodeficiency virus testing is available through the
department of health and certain community agencies;
(3) Providing the person reasonable opportunity to
decline the test; and
(4) Receiving the person's express oral consent to
the test.
A health care provider may, for the purpose of
obtaining consent to the test and in lieu of the oral-consent procedure
specified in this subsection, use a written form that, at a minimum, provides
equivalent information to that prescribed by paragraphs [(1) and (2)]; provided
that the health care provider shall allow the person reasonable opportunity to
decline consent by declining to sign the form.
(b) No blood bank, plasma center, or any other
public or private agency, institution or individual (except a health care
provider acting pursuant to subsections (a) or (c)), may subject a person's
body fluids or tissue to a test for the presence of human immunodeficiency
virus infection unless the subject of the test:
(1) Provides informed written consent pursuant to the
standards in section 671-3 to the testing; and
(2) Is afforded the opportunity to receive human
immunodeficiency virus pre-test counseling by the party ordering or requesting
that the test be performed;
provided that the person tested shall be provided
with the test results by the blood bank, plasma center, agency, institution, or
individual subjecting the person to the test. The opportunity to receive
counseling shall be afforded both prior to obtaining a sample for human
immunodeficiency virus testing, and upon disclosure of the test results,
regardless of the serostatus of the individual tested, except that testing
conducted pursuant to subsection (c)(1) and (2) shall be exempted from the
counseling requirements of this subsection.
(c) Consent to testing is not required for any
of the following:
(1) A health care provider or organ donor center that
procures, processes, distributes, or uses human body parts donated for
scientific purposes, without obtaining consent, may test for the presence of human
immunodeficiency virus to assure medical acceptability of the gift for the
purpose intended;
(2) The department of health, laboratories and
research facilities, health care providers, blood banks, plasma centers, and
educational institutions may subject any body fluids or tissue to be used in
research to a test for human immunodeficiency virus infection if the test is
performed in a manner by which the identity of the test subject is not known
and may not be retrieved by the researcher;
(3) Anonymous testing carried out at human
immunodeficiency virus test sites established by the department of health;
provided that informed oral consent is obtained;
(4) Testing of body fluids or tissue ordered by a
third party, so long as that third party, including an insurance company,
employer, or school, obtains the informed written consent of the person to be
tested authorizing the release of the test results to the third party, and
transmits a signed copy of the written informed consent to the health care provider
prior to any release of the requested test results to the third party. The health care provider shall provide all positive and
indeterminate human immunodeficiency virus test results and offer post-test
counseling to those individuals with positive and indeterminate human
immunodeficiency virus test results;
(5) Informed consent is not required where the
patient is unable to give consent and it is determined by the patient's
treating physician that the patient's human immunodeficiency virus status is
necessary to make a diagnosis or determine an appropriate course of treatment
for the patient. The patient shall be informed in a timely manner that a test
for the presence of human immunodeficiency virus has been performed pursuant to
this paragraph, and the health care provider shall
provide all positive and indeterminate human immunodeficiency virus test results and offer appropriate post-test counseling to
those individuals with positive and indeterminate human immunodeficiency
virus test results;
(6) A treating physician may order a human
immunodeficiency virus test without the patient's informed consent if the
physician has determined that the patient is incapable of giving consent prior
to the rendering of treatment and when there is reason to believe that the
safety of a health care worker may be affected due to exposure to the blood or
bodily fluids of a patient suspected of possible human immunodeficiency virus
infection. The availability and quality of health care services shall not be
compromised based on the findings and testing performed pursuant to this
paragraph. The costs of any testing performed shall be borne by the health
care provider and may not be claimed against the patient or the patient's
health care insurer. The patient and the health care worker shall be informed
in a timely manner that a test for the presence of human immunodeficiency virus
has been performed pursuant to the provisions of this paragraph. The health care provider shall provide all positive and
indeterminate human immunodeficiency virus test results and offer appropriate
post-test counseling to the individual being tested and afford the health care
worker the opportunity to obtain the test results and appropriate post-test
counseling;
(7) A person who has been charged, or a juvenile who
has been charged, pursuant to section 707-730, 707-731, 707-732(1)(a), 707-733.6,
or 707-741 shall be tested to determine the person's human immunodeficiency
virus status upon court order issued pursuant to section 325-16.5. The test
shall be performed according to the protocols set forth in section 325-17; and
(8) A person who has been convicted, or a juvenile
who has been adjudicated, pursuant to section 707-730, 707-731, 707-732(1)(a),
707-733.6, or 707-741 shall be tested to determine the person's human
immunodeficiency virus status upon court order issued pursuant to section 325-16.5.
The test shall be performed according to the protocols set forth in section 325-17.
(d) The confidentiality of all records held
pursuant to this section is governed by section 325-101.
(e) Any person or institution who wilfully
violates any provision of this section shall be fined not less than $1,000 nor
more than $10,000 for each violation plus reasonable court costs and attorney's
fees as determined by the court, which penalty and costs shall be paid to the
person whose records were released. This subsection shall not be construed as
limiting the right of any person or persons to recover actual damages.
(f) The department of health shall make
available to health care providers current information on accessing anonymous
human immunodeficiency virus testing for the purpose of providing that
information to patients.
(g) The department may adopt rules, pursuant
to chapter 91, to establish procedures and standards to implement this section.
(h) As used in this section, "health care provider" means a physician or
surgeon licensed under chapter 453, a podiatrist licensed under chapter 463E, a
health care facility as defined in section 323D-2, and their employees. "Health
care provider" shall not mean any nursing institution or nursing service
conducted by and for those who rely upon treatment by spiritual means through
prayer alone, or employees of such an institution or service.
[L 1987, c 308,
§1; am L 1988, c 192, §1; am L 1989, c 376, §1 and c 377, §3; am L 1998, c 238,
§3; am L 2002, c 238, §2; am L 2006, c 60, §2; am L 2009, c 116, §2]
Source: Hawaii State Legislature (capitol.hawaii.gov), via Internet Archive capturesURL: http://www.capitol.hawaii.gov/hrscurrent/Vol06_Ch0321-0344/HRS0325/HRS_0325-0016.htmFetched: 11/10/2026